Bio-Connect
FACS analysis of human peripheral blood monocytes using GTX01489-10 HLA-DR antibody [LN3] (PE-Cy7). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.125 microg (5 microl)
FACS analysis of human peripheral blood monocytes using GTX01489-10 HLA-DR antibody [LN3] (PE-Cy7). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.125 microg (5 microl)
FACS analysis of human peripheral blood monocytes using GTX01489-10 HLA-DR antibody [LN3] (PE-Cy7). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.125 microg (5 microl)

HLA-DR antibody [LN3] (PE-Cy7)

Research Use Only
GTX01489-10
GeneTex
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman
TargetHLA-DRA
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    HLA-DR antibody [LN3] (PE-Cy7)
  • Delivery Days Customer
    9
  • Application Supplier Note
    FACS: 0.125 microg (5 microl) for 105-108 cells in 100 microl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    LN3
  • Concentration
    0.025 mg/ml
  • Conjugate
    Double Conjugated
  • Formulation
    Liquid
  • Gene ID3122
  • Target name
    HLA-DRA
  • Target description
    major histocompatibility complex, class II, DR alpha
  • Target synonyms
    histocompatibility antigen HLA-DR alpha; HLA class II histocompatibility antigen, DR alpha chain; HLA-DRA1; MHC class II antigen DRA
  • Host
    Mouse
  • Isotype
    IgG2b
  • Protein IDP01903
  • Protein Name
    HLA class II histocompatibility antigen, DR alpha chain
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Identification of plasmacytoid T cells in lymphoid hyperplasia of the skin. Eckert F et al., 1989 Nov, Arch Dermatol
    Read more